Investing Profile

David Goeddel

InvestorVC

Managing Partner at The Column Group

Your Intro Paths to David Goeddel

Signal uses Gmail to reveal intro paths. Email content is never read.

Find David Goeddel on

Current Investing Position

The Column Group Managing Partner

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Current Fund Size

$600M

David Goeddel is on these Sector & Stage Rankings

David Goeddel's Investments On Record (8)

Company	StageDateRound Size	Total Raised
Hexagon Bio	Series BOct 2022$77M Series UnknownSep 2021$61M Series ASep 2020$47M	$190M
Co-investors: Alex Kolicich (8VC), Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures)
Peloton Therapeutics	Series EFeb 2019$150M Series DSep 2016$52M Series AJul 2011$18M	$280M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Derek DiRocco (RA Capital), Jim Tananbaum (Foresite Capital)
Exonics Therapeutics	Series ANov 2017$40M	$40M
NGM Biopharmaceuticals	Series DMar 2015$58M Series BMar 2010$55M Series ADec 2009$27M	$260M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences	Series BDec 2014$38M	$66M
Co-investors: Beth Seidenberg (Westlake Village BioPartners)
Nurix Therapeutics	Series BMay 2014$25M Series UnknownMar 2013$5M SeedMay 2012$3M	$150M
Co-investors: Michael Rome (Foresite Capital)
Igenica	Series CJan 2014$14M Series CJun 2012$33M Series BJun 2010$24M Series AJan 2009$3M	$74M
Co-investors: Richard Ulevitch (5am Ventures), Carl Gordon (OrbiMed)
Constellation Pharmaceuticals	Series CJan 2012$95M	$390M
Co-investors: Robert Tepper (Third Rock Ventures), Tony Evnin (Venrock), Brian Gallagher (Abingworth)